Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Biochemical Pharmacology of Lipophilic Diaminopyrimidine Antifolates in Mouse and Human Cells in Vitro

WILLIAM R. GRECO and MAIRE T. HAKALA
Molecular Pharmacology November 1980, 18 (3) 521-528;
WILLIAM R. GRECO
Department of Experimental Therapeutics, Roswell Park Memorial Institute, Buffalo, New York 14263, and Department of Pharmacology and Therapeutics, State University of New York at Buffalo, Buffalo, New York 14214
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAIRE T. HAKALA
Department of Experimental Therapeutics, Roswell Park Memorial Institute, Buffalo, New York 14263, and Department of Pharmacology and Therapeutics, State University of New York at Buffalo, Buffalo, New York 14214
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Four lipophilic 2,4-diaminopyrimidine antifolates, 2,4-diamino-5-(1-adamantyl)-6-ethylpyrimidine (DAEP), 2,4-diamino-5-(1-adamantyl)-6-methylpyrimidine (DAMP), 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP), and 2,4-diamino-5-(p-chlorophenyl)-6-ethylpyrimidine (PRM), were examined in cultures of several mouse and human cell lines and compared with methotrexate (MTX). Unlike MTX, the diaminopyrimidines not only inhibited dihydrofolate reductase, but were found to have a second, folate-independent site of action as judged by growth inhibition in a medium supplemented with the products of folate-dependent reactions (hypoxanthine, thymidine, and glycine). With respect to this site of inhibition, DAEP, DAMP, and DDMP were equipotent, with an ID50 for all cells in the range of 5-50 µM. The second site did not concern DNA polymerases α,β, or γ (EC 2.7.7.7), and excess methionine did not alleviate the inhibition. When folates in the medium were present at concentrations adequate for optimal growth (folic acid and N5-methy-H4 folic acid at 1 µM, folinic acid at 0.01 µM), the growth inhibitory potency of DAMP was the same. Increased concentrations of folinic acid protected the cells against DAMP to a certain degree, but not as well as hypoxanthine and thymidine. This is unlike MTX, which is competitively antagonized by folinic acid. Folinic acid and the products could also, to a limited degree, rescue cells preexposed to DAMP. Under folate-dependent conditions the growth of human cells was, on the average, four to eight times less sensitive to inhibition by DAEP, DAMP, and DDMP than that of mouse cells. This is unlike MTX. Neither the velocity or extent of cellular uptake of diaminopyrimidines nor the level of dihydrofolate reductase (EC 1.5.1.3) or the activity of TMP synthetase (EC 2.1.1.6) correlated with these sensitivities. No cellular metabolism of DAMP or DDMP was detected. The apparent affinities of the diaminopyrimidines to human and mouse dihydrofolate reductases may help explain the different sensitivities of cells to growth inhibition. While DAEP was the most potent growth inhibitor, with an ID50 in the 1 to 40 nM range for all cells examined, the average ID50 values for DAEP, DAMP, DDMP, and PRM related as 1:4:13:300. The true Ki values for DAEP, DAMP, and DDMP were 0.14, 0.68, and 2.1 nM, respectively, for the dihydrofolate reductase purified from MTX-resistant S-180 cells and 0.14, 0.43, and 1.0 nM, respectively, for the enzyme of MTX-resistrant KB cells. There was a positive correlation between the ID50 values for growth inhibition by the various compounds and the Ki values for dihydrofolate reductase.

  • Copyright © 1980 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 18, Issue 3
1 Nov 1980
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Biochemical Pharmacology of Lipophilic Diaminopyrimidine Antifolates in Mouse and Human Cells in Vitro
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Biochemical Pharmacology of Lipophilic Diaminopyrimidine Antifolates in Mouse and Human Cells in Vitro

WILLIAM R. GRECO and MAIRE T. HAKALA
Molecular Pharmacology November 1, 1980, 18 (3) 521-528;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Biochemical Pharmacology of Lipophilic Diaminopyrimidine Antifolates in Mouse and Human Cells in Vitro

WILLIAM R. GRECO and MAIRE T. HAKALA
Molecular Pharmacology November 1, 1980, 18 (3) 521-528;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics